ABSTRACT

Intellectual Assets has become the pre-eminent resource for creating economic wealth. Intellectual Assets has contributed to the creation of whole new types of businesses and ways of doing business. In the Knowledge based industries many firms have large amounts of Intellectual Assets such as brand names, patents or employees’ expertise. These assets represent a substantial portion of the Market Value of a firm. But the Accounting Standards worldwide are yet to grip with the reality that those investments in Intellectual Assets are ‘Capital’ investments, and not ‘Current’ expenses. Consequent to such a treatment, there can be potentially large effects on profitability or book values of many firms. These consequences raise the question whether Stock prices reflected in the Market Value of the firms fully incorporate the value of Intellectual Assets. This study has greater scope due to the increasing level of importance given by Indian Pharmaceutical companies in getting their IP Protection and numerous problems faced by them in every stage and the cost involved. Keywords: Intellectual Property Rights, Patent, Research & Development, Clinical Trials, Copyrights, Generic Drugs etc.
Publication date: 01/10/2021

https://ijbpas.com/pdf/2021/October/MS_IJBPAS_2021_OCT_SPCL_1027.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2021/10.10.1027